Ilex Medical Ltd (TLV:ILX)

Ilex Medical Income Statement

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	920.37	916.25	863.28	1,061	946.45
Revenue Growth (YoY)	0.45%	6.13%	-18.63%	12.10%	49.29%
Cost of Revenue	704.06	689.34	580.37	681.61	675.43
Gross Profit	216.31	226.9	282.91	379.38	271.02
Selling, General & Admin	143.77	142.6	132.77	126.84	117.95
Research & Development	7.62	6.85	5.89	8.35	8.42
Other Operating Expenses	2	-0.02	-2.1	-1.95	-1.86
Operating Expenses	153.38	149.42	136.56	133.24	124.51
Operating Income	62.93	77.48	146.35	246.14	146.51
Interest Expense	-2.34	-1.78	-1.57	-1.97	-2.34
Interest & Investment Income	7.85	5.74	1.86	1.86	0.85
Earnings From Equity Investments	-7.19	-4.01	-2.69	-0.26	-
Currency Exchange Gain (Loss)	0.22	-5.23	-10.27	-1.59	5.12
Other Non Operating Income (Expenses)	-3.74	-2.78	-9.84	7.4	3.94
EBT Excluding Unusual Items	57.73	69.43	123.85	251.58	154.07
Gain (Loss) on Sale of Investments	4.32	4.37	-2.72	3.78	0.09
Gain (Loss) on Sale of Assets	-0.46	0.24	21.96	-0.01	-0.36
Pretax Income	61.6	74.04	143.09	255.35	153.8
Income Tax Expense	15.89	18.51	34.6	57.87	27.83
Earnings From Continuing Operations	45.7	55.53	108.49	197.48	125.97
Earnings From Discontinued Operations	-6.72	-4.64	-6.37	-	-
Net Income to Company	38.98	50.89	102.12	197.48	125.97
Minority Interest in Earnings	-	-	-	-	-5.35
Net Income	38.98	50.89	102.12	197.48	120.62
Net Income to Common	38.98	50.89	102.12	197.48	120.62
Net Income Growth	-23.39%	-50.17%	-48.29%	63.72%	100.18%
Shares Outstanding (Basic)	11	11	11	11	11
Shares Outstanding (Diluted)	11	11	11	11	11
Shares Change (YoY)	-0.02%	-0.79%	-0.02%	5.73%	6.33%
EPS (Basic)	3.48	4.55	9.05	17.51	11.30
EPS (Diluted)	3.48	4.55	9.05	17.50	11.24
EPS Growth	-23.34%	-49.80%	-48.27%	55.66%	87.41%
Free Cash Flow	51.87	31.66	43.6	229.73	138.1
Free Cash Flow Per Share	4.64	2.83	3.87	20.36	12.94
Dividend Per Share	1.220	1.365	1.917	5.319	5.319
Dividend Growth	-10.63%	-28.80%	-63.97%	-	-
Gross Margin	23.50%	24.76%	32.77%	35.76%	28.63%
Operating Margin	6.84%	8.46%	16.95%	23.20%	15.48%
Profit Margin	4.23%	5.55%	11.83%	18.61%	12.75%
Free Cash Flow Margin	5.64%	3.46%	5.05%	21.65%	14.59%
EBITDA	96.72	111	196.39	296.63	186.4
EBITDA Margin	10.51%	12.12%	22.75%	27.96%	19.70%
D&A For EBITDA	33.79	33.52	50.04	50.49	39.89
EBIT	62.93	77.48	146.35	246.14	146.51
EBIT Margin	6.84%	8.46%	16.95%	23.20%	15.48%
Effective Tax Rate	25.80%	25.00%	24.18%	22.66%	18.10%
Advertising Expenses	3.53	3.64	3.4	1.4	1.89

Updated Nov 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.